论文部分内容阅读
强化他汀治疗是急性心肌梗死(AMI)二级预防的核心内容,尤其对高危患者,例如糖尿病(DM)患者更是如此。研究者记录了24家美国注册医院中患AMI的DM患者在出院时强化他汀治疗的状况(强化他汀治疗定义为预期LDL-C降低幅度>50%)。强化他汀治疗的预测因素用多变量回归模型来评估。在1 300例AMI后的DM患者中,22%出院时给予强化他汀治疗。在多变量模型中,STEMI(RR:1.48,95%Cl:1.29~1.70),医药保险(RR:
Intensive statin therapy is at the heart of secondary prevention of acute myocardial infarction (AMI), especially in high-risk patients, such as people with diabetes mellitus (DM). The researchers documented the statin-intensive condition at discharge from patients with AMI in 24 U.S. registered hospitals (defined as the expected> 50% reduction in LDL-C). Predictors of intensive statin therapy were evaluated using a multivariate regression model. Of the 1,300 DM patients who had AMI, 22% were given statin therapy at discharge. In the multivariate model, STEMI (RR: 1.48, 95% Cl: 1.29-1.70), Medicare (RR: